Linqi Z. Zhang
No 600, Tianhe Road
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
[18F]FAPI-04 PET/CT for detection of recurrent breast cancer after surgery: a post hoc analysis comparing [18F]FDG PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 08, 2026
Editorial for "Diffusion Relaxation-Correlated Spectroscopic MR Imaging for in Vivo Tumor Heterogeneity and Lymph Node Metastasis Prediction in Oral Tongue Squamous Cell Carcinoma".
Journal: Journal of magnetic resonance imaging : JMRI
Published: January 08, 2026
Diagnostic value of [18F]FAPI-04 PET/CT in patients with monofocal liver lesions suspicious for hepatocellular carcinoma: a prospective comparison with LI-RADS-based contrast-enhanced CT/MRI.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 04, 2026
Editorial for "Characterization of Intratumoral Heterogeneity via MRI-Based Radiomic Habitats in Osteosarcoma".
Journal: Journal of magnetic resonance imaging : JMRI
Published: December 16, 2025
Superiority of 18 F-FAPI PET/CT to 18 F-FDG PET/CT in the Evaluation of Synchronous Renal and Uterine PEComa.
Journal: Clinical nuclear medicine
Published: April 07, 2025
Diagnostic performance of [18F]FAPI-04 PET/CT in suspected recurrent hepatocellular carcinoma: prospective comparison with contrast-enhanced CT/MRI.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 20, 2025
[18F]-FAPI-04 PET/CT improves metastatic lesions detection for patients with uterine malignancy after radical surgery: prospectively compared with [18F]-FDG PET/CT.
Journal: European journal of radiology
Published: November 23, 2024
New strategy of LI-RADS v2018 to improve the sensitivity for small hepatocellular carcinoma ≤ 3.0 cm on extracellular-contrast enhanced MRI.
Journal: European journal of radiology
Published: August 22, 2024
Role of [18F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [18F]FDG PET/CT.
Journal: EJNMMI research
Published: June 04, 2024
Intense 18 F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18 F-FDG PET/CT.
Journal: Clinical nuclear medicine
Published: April 03, 2024
Intertumoral Heterogeneity Based on MRI Radiomic Features Estimates Recurrence in Hepatocellular Carcinoma.
Journal: Journal of magnetic resonance imaging : JMRI
Published: February 17, 2024
Head-to-head comparison between [68Ga]Ga-DOTA-NOC and [18F]DOPA PET/CT in a diverse cohort of patients with pheochromocytomas and paragangliomas.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 19, 2023
Last Updated: 09/26/2026